Trademark search for:

ENBIVINC

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2017-03-01 — Application filed
2017-03-04 — Application filed
2017-03-08 — Application filed
2017-03-08 — Teas voluntary amendment received
2017-03-23 — Assigned to lie
2017-03-29 — Preliminary/voluntary amendment - entered
2017-05-22 — Assigned to examiner
2017-05-24 — Examiners amendment e-mailed
2017-05-24 — Notification of examiners amendment e-mailed
2017-05-24 — Examiners amendment -written
2017-05-24 — Examiner's amendment entered
2017-05-24 — Approved for pub - principal register
2017-05-31 — Law office publication review completed
2017-06-14 — Notification of notice of publication e-mailed
2017-07-04 — Published for opposition
2017-07-04 — Official gazette publication confirmation e-mailed
2017-09-19 — Registered-principal register
2022-09-19 — Courtesy reminder - sec. 8 (6-yr) e-mailed
2024-03-29 — Cancelled sec. 8 (6-yr)
2024-03-29 — Final status recorded

Owner Information

Samsung Bioepis Co., Ltd.
Incheon KR

Correspondent

STEPHEN R. BARRESE, ESQ. DILWORTH & BARRESE, LLP
1000 WOODBURY ROAD, SUITE 405
WOODBURY, NY 11797
UNITED STATES

Filing Details

Filing Date:
2017-03-01

Status Date:
2024-03-29

Category:
Pharmaceuticals

Filing Year:
2017

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.